Evidence map›Paper›PMID 42236650›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2026

Performance of disk diffusion and MIC gradient tests in tigecycline susceptibility testing of enterococci: a Nordic multicentre study.

Ingeborg Mathiesen, Bjørg Christina Haldorsen, Lars Småbrekke, Erika Matuschek, Frode Skjold, Barbara Juliane Holzknecht, Kristján Orri Helgason, Heikki Ilmavirta, Gunnar Kahlmeter, Arnfinn Sundsfjord and 2 more

Abstract readMulticenter Study
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ingeborg MathiesenResearch Group for Host-Microbe Interactions, Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.ORCID http://orcid.org/0000-0002-9179-1965
Bjørg Christina HaldorsenNorwegian Centre for Detection of Antimicrobial Resistance, Department of Microbiology and Infection Control, University Hospital of North Norway, Tromsø, 9037, Norway.ORCID http://orcid.org/0009-0000-1743-6407
Lars SmåbrekkeDepartment of Pharmacy, UiT The Arctic University of Norway, Tromsø, Norway.ORCID http://orcid.org/0000-0001-6475-3368
Erika MatuschekEUCAST Development Laboratory, Clinical Microbiology, Växjö Hospital, Växjö, Sweden.ORCID http://orcid.org/0000-0001-8163-3667
Frode SkjoldDepartment of Pharmacy, UiT The Arctic University of Norway, Tromsø, Norway.
Barbara Juliane HolzknechtDepartment of Clinical Microbiology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.ORCID http://orcid.org/0000-0002-0320-5242
Kristján Orri HelgasonDepartment of Clinical Microbiology, Landspitali University Hospital of Iceland, Reykjavik, Iceland.
Heikki IlmavirtaDepartment of Clinical Microbiology, University of Eastern Finland, Kuopio, Finland.
Gunnar KahlmeterEUCAST Development Laboratory, Clinical Microbiology, Växjö Hospital, Växjö, Sweden.
Arnfinn SundsfjordResearch Group for Host-Microbe Interactions, Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway.ORCID http://orcid.org/0000-0002-3728-2270
Kristin HegstadResearch Group for Host-Microbe Interactions, Department of Medical Biology, Faculty of Health Sciences, UiT The Arctic University of Norway, Tromsø, Norway. Kristin.Hegstad@uit.no.ORCID http://orcid.org/0000-0002-1314-0497
NordicAST 2023 LRE-TRE Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeEvaluating the performance of the European Committee on Antimicrobial Susceptibility Testing (EUCAST) disk diffusion (DD) and minimum inhibitory concentration (MIC) gradient methods for tigecycline susceptibility testing of enterococci using broth microdilution (BMD) as the reference method.

methodsAll 83 Nordic clinical microbiology laboratories were invited to test a blinded collection of diverse whole genome sequenced Enterococcus faecalis (n = 10) and Enterococcus faecium (n = 10) strains using the EUCAST DD and gradient MIC methods (Etest or MTS). Results were compared to reference BMD MICs and genotype (presence/absence of known tigecycline resistance determinants). Categorical agreement (CA), essential agreement (EA), and bias were calculated according to international standards.

resultsForty-four laboratories contributed to 880 EUCAST DD and 800 MIC gradient test observations. The EUCAST DD method demonstrated a CA of 97.3% when compared to reference MIC and 93.0% when compared to genotype. Gradient tests achieved an overall EA of 95.9% (Etest: 96.3%; MTS: 95.5%) and a CA of 96.3% when compared to reference MICs and 96.5% when compared to genotype. Both Etest and MTS exhibited acceptable bias (Etest: +21.8%; MTS: -19.1%).

conclusionThe EUCAST DD method and gradient tests demonstrated acceptable performance in accordance with international standards. Errors were mainly related to borderline strains near the tigecycline breakpoint. Further research is required on tigecycline-resistant enterococci and the development of improved AST methods for categorisation of borderline strains.

Indexed as

Anti-Bacterial AgentsDisk Diffusion Antimicrobial TestsEnterococcus faecalisEnterococcus faeciumTigecyclineGenotypeGram-Positive Bacterial InfectionsHumansMicrobial Sensitivity TestsScandinavian and Nordic CountriesAnti-Bacterial AgentsTigecyclineBroth microdilutionDisk diffusionEnterococcusEUCASTGradient testTigecycline

Identifiers

PMID42236650
PMCPMC13593673

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.